Author

T. Bopp

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:mouse· 3 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1

Frequent Co-Authors

M. Klein· 2 shared A. Burchert· 1 shared A. Gabele· 1 shared A. M. Hartmann· 1 shared A. Neubauer· 1 shared A. Nist· 1 shared A. Pagenstecher· 1 shared A. Schippers· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

M. Klein

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CREB REGULATES FOXP3+ST-2+ TREGS WITH ENHANCED IL-10 PRODUCTION

S. Hebbar Subramanyam, J. Hriczko, S. Schulz, T. Look, T. Goodarzi, T. Clarner, M. Scheld, M. Kipp, E. Verjans, S. Boell, C. Neullens, I. Costa, Z. Li, L. Gan, B. Denecke, , K. Tenbrock

This study shows that CREB knockout in Foxp3+ Tregs increases IL-10 and ST-2 expression, enhancing their suppressive function and preventing gut inflammation.

bioRxiv · Jun 29, 2024Immunology

Unveiling IRF4-steered regulation of context-dependent effector programs in Th17 and Treg cells

A. Gabele, M. Sprang, M. Cihan, S. Dietzen, M. Klein, G. Harms, T. Ziesmann, K. Pape, B. Wasser, D. Gomez-Zepeda, K. Braband, M. Delacher, N. Lemmermann, S. Bittner, M. A. Andrade-Navarro, , U. Distler

This study identifies IRF4 interactors and their role in regulating context-dependent transcriptional programs in Th17 and Treg cells using ChIP-Seq and proteomics.

bioRxiv · Sep 14, 2023 · PreprintImmunology

IRF4 deficiency vulnerates B cell progeny for leukemogenesis via somatically acquired Jak3 mutations conferring IL-7 hypersensitivity

D. Das Gupta, C. Paul, N. Samel, M. Bieringer, D. Staudenraus, F. Marini, H. Raifer, L. Menke, L. Hansal, B. Camara, E. Roth, P. Daum, M. Wanzel, M. Mernberger, A. Nist, , M. Lohoff

This study shows IRF4 deficiency leads to B cell leukemia via Jak3 mutations that increase IL-7 sensitivity, and JAK inhibition improves survival in a mouse model.

bioRxiv · Feb 16, 2022 · PreprintCancer Biology